Background: Advanced abdomino-pelvic tumors are often unresectable using surgery alone. The current study evaluated a combination of radiofrequency (RF) ablation (RFA) and surgical debulking for such lesions.

Methods: Between July 2003 and November 2004, we treated 16 patients. Fourteen had either pelvic side wall (n = 8), sacro-iliac joint (n = 4), or vertebral (n = 2) fixation. One tumor engulfed root of mesentery, the last involved stomach-liver-vena. All patients had received prior treatment. The RF probe was placed in the center of the tumor, a 4- to 6-cm tissue core ablated, and the core curetted out or aspirated. This was repeated centrifugally out to the tumor capsule.

Results: Control of the target lesion for more than 6 months was achieved in 10 (62%) patients; 2 died within 3 months, and 4 had tumor progression in less than 6 months. Median survival is 18+ months.

Conclusions: Combined RFA-surgical debulking was feasible and beneficial in 62%% of patients with otherwise inoperable abdomino-pelvic tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2006.08.053DOI Listing

Publication Analysis

Top Keywords

abdomino-pelvic tumors
12
advanced abdomino-pelvic
8
combined radiofrequency-surgical
4
radiofrequency-surgical debulking
4
debulking advanced
4
tumors background
4
background advanced
4
tumors unresectable
4
unresectable surgery
4
surgery current
4

Similar Publications

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal tumors that arise from interstitial cells of Cajal. Due to vague presentation, location and confusing imaging studies, they tend to mimic gynaecological tumors. They usually diagnosed intra-operative and histopathology followed by tumor specific receptors such as KIT, CD34, CD 117 and DOG 1 are mainstay of diagnosis of GIST.

View Article and Find Full Text PDF

Background: Image-defined risk factors (IDRFs) were introduced to provide a consensus approach for pre-treatment risk stratification on computed tomography (CT) and magnetic resonance imaging (MRI) in patients with neuroblastoma.

Objective: To assess the intra- and inter-reader agreement of radiologists in identifying IDRFs on CT.

Materials And Methods: Approval for this retrospective study was granted by our institutional research ethics board with a waiver of consent.

View Article and Find Full Text PDF

Introduction And Importance: Presentation of a giant para-ovarian cysts is rarely reported in the literature, with varying symptoms, methods of treatment, and complications. Herein, we highlight the diagnostic challenges faced in a low resource setting in the diagnosis of a giant para-ovarian cyst in a 17-year-old girl.

Case Presentation: A 17-year-old, virginal girl who presented with vague abdominal pain with an abdomino-pelvic mass of about 24 weeks pregnancy uterus size was diagnosed as a case of huge benign ovarian cyst with normal tumour markers.

View Article and Find Full Text PDF

French AFU Cancer Committee Guidelines - Update 2024-2026: Testicular germ cell cancer.

Fr J Urol

November 2024

Comité de Cancérologie de l'Association Française d'Urologie, groupe organes génitaux externes, Maison de l'Urologie, 11, rue Viète, 75017 Paris, France; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitié-Salpêtrière Hospital, 75013 Paris, France.

Article Synopsis
  • The objective of the review is to update guidelines for managing testicular germ cell tumors (TGT) based on recent literature from 2022.
  • Initial diagnosis involves clinical exam, serum marker levels (AFP, hCG, LDH), and imaging techniques like ultrasound and CT scans; treatment starts with inguinal orchiectomy which helps in defining the tumor stage and treatment approach.
  • For specific stages of the tumors, treatment strategies vary, including surveillance for stage I seminomas, risk-adapted options for stage I non-seminomatous tumors, and chemotherapy for metastatic cases, with additional measures like radiotherapy for certain seminoma stages.
View Article and Find Full Text PDF

A Sister Mary Joseph's nodule (SMJN) is characterized by a palpable umbilical nodule and is often a clinical indicator of the metastasis of an advanced abdominal or pelvic malignancy. Observing the cutaneous manifestation of an abdomino-pelvic malignancy is a relatively rare phenomenon due to the appearance of visible changes in the later stages of the disease. With the pancreas being a less common primary tumor site for SMJN, this case report describes a 57-year-old male diagnosed with metastatic pancreatic adenocarcinoma with a SMJN.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!